Logo image of MEDP

MEDPACE HOLDINGS INC (MEDP) Stock Analyst Earnings Estimates

NASDAQ:MEDP - Nasdaq - US58506Q1094 - Common Stock - Currency: USD

434.35  +5.56 (+1.3%)

After market: 434.35 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
MEDP revenue by date.MEDP revenue by date.
1.46B
27.80%
1.886B
29.17%
2.109B
11.84%
2.513B
19.15%
2.748B
9.35%
3.016B
9.75%
2.71B
-10.15%
2.949B
8.82%
3.107B
5.36%
3.392B
9.17%
3.707B
9.29%
EBITDA
YoY % growth
MEDP ebitda by date.MEDP ebitda by date.
301.1M
37.05%
363.153M
20.61%
476.121M
31.11%
536.88M
12.76%
579.43M
7.93%
639.51M
10.37%
614.65M
-3.89%
687.68M
11.88%
753.28M
9.54%
839.55M
11.45%
936.06M
11.50%
EBIT
YoY % growth
MEDP ebit by date.MEDP ebit by date.
278.7M
40.33%
336.825M
20.86%
446.87M
32.67%
511.24M
14.40%
548.99M
7.38%
608.04M
10.76%
582.01M
-4.28%
653.34M
12.26%
713.84M
9.26%
797.41M
11.71%
891.06M
11.74%
Operating Margin
MEDP operating margin by date.MEDP operating margin by date.
19.09%17.86%21.19%20.34%19.98%20.16%21.48%22.15%22.98%23.51%24.04%
EPS
YoY % growth
MEDP eps by date.MEDP eps by date.
7.32
52.18%
8.88
21.31%
12.63
42.23%
13.00
2.91%
13.43
3.30%
14.86
10.65%
16.68
12.26%
18.82
12.87%
20.94
11.24%
23.36
11.57%
26.08
11.64%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
3.58
18.95%
3.83
4.30%
3.18
-13.27%
3.44
10.82%
3.56
-0.63%
3.81
-0.50%
3.97
24.76%
4.15
20.74%
4.29
20.70%
4.55
19.44%
Revenue
Q2Q % growth
653.31M
22.50%
672.5M
25.33%
560.12M
0.28%
596.07M
-1.20%
619.15M
-5.23%
640.91M
-4.70%
652.84M
16.55%
673.8M
13.04%
698.34M
12.79%
725.14M
13.14%
EBITDA
Q2Q % growth
137.34M
2.48%
143.86M
-6.96%
121.12M
0.55%
129.86M
-7.43%
133.68M
-2.66%
142.14M
-1.20%
150.9M
24.59%
155.86M
20.02%
159.99M
19.68%
167M
17.49%
EBIT
Q2Q % growth
129.77M
15.58%
136.44M
8.82%
113.16M
-0.32%
121.75M
-3.63%
126.22M
-2.74%
136.14M
-0.22%
143.01M
26.38%
147.91M
21.49%
151.87M
20.32%
158.74M
16.60%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
3.10
12.73%
3.020.082.57%
Q1 2025
Q2Q % growth
3.67
14.69%
3.110.5617.84%
Q4 2024
Q2Q % growth
3.67
49.19%
3.020.6521.62%
Q3 2024
Q2Q % growth
3.01
35.59%
2.830.186.19%
Q2 2024
Q2Q % growth
2.75
42.49%
2.590.166.29%
Q1 2024
Q2Q % growth
3.20
40.97%
2.510.6927.27%
Q4 2023
Q2Q % growth
2.46
16.04%
2.270.198.54%
Q3 2023
Q2Q % growth
2.22
8.29%
2.090.136.38%
Q2 2023
Q2Q % growth
1.93
32.19%
1.95-0.02-1.18%
Q1 2023
Q2Q % growth
2.27
34.32%
1.840.4323.57%
Q4 2022
Q2Q % growth
2.12
60.61%
1.820.3016.37%
Q3 2022
Q2Q % growth
2.05
58.91%
1.500.5536.37%
Q2 2022
Q2Q % growth
1.46
37.74%
1.340.129.10%
Q1 2022
Q2Q % growth
1.69
48.25%
1.290.4031.39%
Q4 2021
Q2Q % growth
1.32
-2.22%
1.280.043.45%
Q3 2021
Q2Q % growth
1.29
18.35%
1.100.1917.78%
Q2 2021
Q2Q % growth
1.06
55.88%
1.010.055.01%
Q1 2021
Q2Q % growth
1.14
42.50%
1.020.1211.36%
Q4 2020
Q2Q % growth
1.35
58.82%
1.270.086.66%
Q3 2020
Q2Q % growth
1.09
53.52%
1.10-0.01-0.48%
Q2 2020
Q2Q % growth
0.68
-16.05%
0.420.2661.20%
Q1 2020
Q2Q % growth
0.80
25.00%
0.760.044.92%
Q4 2019
Q2Q % growth
0.85 0.770.0810.57%
Q3 2019
Q2Q % growth
0.71 0.73-0.02-2.35%
Q2 2019
Q2Q % growth
0.81 0.650.1625.02%
Q1 2019
Q2Q % growth
0.64 0.610.034.48%
MEDP Yearly EPS VS EstimatesMEDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5 10 15 20 25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
603.311M
14.24%
549.55M53.761M9.78%
Q1 2025
Q2Q % growth
558.57M
9.30%
536.87M21.7M4.04%
Q4 2024
Q2Q % growth
536.589M
7.66%
545.48M-8.891M-1.63%
Q3 2024
Q2Q % growth
533.317M
8.29%
551.81M-18.493M-3.35%
Q2 2024
Q2Q % growth
528.104M
14.59%
539.19M-11.086M-2.06%
Q1 2024
Q2Q % growth
511.044M
17.72%
522.84M-11.796M-2.26%
Q4 2023
Q2Q % growth
498.401M
26.47%
508.69M-10.289M-2.02%
Q3 2023
Q2Q % growth
492.499M
28.36%
485.27M7.229M1.49%
Q2 2023
Q2Q % growth
460.868M
31.23%
442.37M18.498M4.18%
Q1 2023
Q2Q % growth
434.1M
31.19%
409.84M24.26M5.92%
Q4 2022
Q2Q % growth
394.1M
27.71%
393.73M370K0.09%
Q3 2022
Q2Q % growth
383.7M
29.80%
364.33M19.37M5.32%
Q2 2022
Q2Q % growth
351.2M
26.19%
350.9M300K0.09%
Q1 2022
Q2Q % growth
330.9M
27.27%
333.64M-2.74M-0.82%
Q4 2021
Q2Q % growth
308.6M
18.83%
315.22M-6.62M-2.10%
Q3 2021
Q2Q % growth
295.6M
28.30%
297.39M-1.79M-0.60%
Q2 2021
Q2Q % growth
278.3M
35.76%
277.54M760K0.27%
Q1 2021
Q2Q % growth
260M
12.60%
270.59M-10.59M-3.91%
Q4 2020
Q2Q % growth
259.7M
12.96%
250.88M8.82M3.52%
Q3 2020
Q2Q % growth
230.4M
6.57%
228.03M2.37M1.04%
Q2 2020
Q2Q % growth
205M
-4.25%
184.14M20.86M11.33%
Q1 2020
Q2Q % growth
230.9M
15.05%
230.5M400K0.17%
Q4 2019
Q2Q % growth
229.9M 226.17M3.73M1.65%
Q3 2019
Q2Q % growth
216.2M 221.48M-5.28M-2.38%
Q2 2019
Q2Q % growth
214.1M 205M9.1M4.44%
Q1 2019
Q2Q % growth
200.7M 194.14M6.56M3.38%
MEDP Yearly Revenue VS EstimatesMEDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS16.97% 15.16% 0% 3.86%
Revenue17.91% 17.4% 12.74% 13.1%